Cytosorbents (CTSO) Return on Capital Employed Growth (3y) (2014 - 2026)
Cytosorbents (CTSO) Return on Capital Employed Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | -236.00 |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 281.00 |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 145.00 |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 446.00 |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | -433.00 |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 1,627.00 |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | -62.00 |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | - |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 370.00 |
| 10 | Cytosorbents | 21.98 Mn | 17.56 Mn | 7.05 Mn | -1,852.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1,852.00 |
| Mar 31, 2026 | 879.00 |
| Dec 31, 2025 | 1,760.00 |
| Sep 30, 2025 | 2,390.00 |
| Jun 30, 2025 | 689.00 |
| Mar 31, 2025 | -127.00 |
| Dec 31, 2024 | -1,463.00 |
| Sep 30, 2024 | -3,458.00 |
| Jun 30, 2024 | -4,645.00 |
| Mar 31, 2024 | -6,141.00 |
| Dec 31, 2023 | -7,422.00 |
| Sep 30, 2023 | -5,128.00 |
| Jun 30, 2023 | -1,215.00 |
| Mar 31, 2023 | 840.00 |
| Dec 31, 2022 | 4,542.00 |
| Sep 30, 2022 | 3,787.00 |
| Jun 30, 2022 | 2,438.00 |
| Mar 31, 2022 | 2,619.00 |
| Dec 31, 2021 | 2,814.00 |
| Sep 30, 2021 | 2,702.00 |